|
FGF23 and the role of cardiac mitochondria in heart failure specific to CKD |
02/03/2023 - 9:00am to 10:00am EST |
|
GLP-1 Receptor Agonist use in ESKD |
04/28/2023 - 9:00am to 10:00am EDT |
|
Grief 101: How to Support our Patients, Families and Ourselves |
11/10/2023 - 9:00am to 10:00am EST |
|
Immune Mechanisms of Hypertension and Heart Failure |
09/22/2023 - 9:00am to 10:00am EDT |
|
Inflammation and the Kidney Tissue Microenvironment |
10/27/2023 - 9:00am to 10:00am EDT |
|
Inpatient Hypertension: Should we treat? |
03/10/2023 - 9:00am to 10:00am EST |
|
Lies, Damned Lies and Statistics: Medicine in the Age of Alternative Facts |
02/10/2023 - 9:00am to 10:00am EST |
|
Localization and Functional Characterization of the Cannabinoid Receptor Type 1 (CB1R) in the Kidney |
12/08/2023 - 9:00am to 10:00am EST |
|
Mineralocorticoid Receptor Antagonism (MRA) in CKD |
06/02/2023 - 9:00am to 10:00am EDT |
|
Navigating to Kidney Health Equity: Delving Below The Tip of The Iceberg To Understand and Address Racial Disparities in Kidney Disease |
10/20/2023 - 9:00am to 10:00am EDT |
Facebook
Twitter
LinkedIn
Forward